These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 12270146)

  • 41. Ectodomain shedding of TGF-alpha and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascades.
    Fan H; Derynck R
    EMBO J; 1999 Dec; 18(24):6962-72. PubMed ID: 10601018
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proliferation of IL-6-independent multiple myeloma does not require the activity of extracellular signal-regulated kinases (ERK1/2).
    Zhang B; Fenton RG
    J Cell Physiol; 2002 Oct; 193(1):42-54. PubMed ID: 12209879
    [TBL] [Abstract][Full Text] [Related]  

  • 43. CD40-mediated signaling in monocytic cells: up-regulation of tumor necrosis factor receptor-associated factor mRNAs and activation of mitogen-activated protein kinase signaling pathways.
    Pearson LL; Castle BE; Kehry MR
    Int Immunol; 2001 Mar; 13(3):273-83. PubMed ID: 11222496
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The MEK-1/ERKs signalling pathway is differentially involved in the self-renewal of early and late avian erythroid progenitor cells.
    Dazy S; Damiola F; Parisey N; Beug H; Gandrillon O
    Oncogene; 2003 Dec; 22(58):9205-16. PubMed ID: 14681680
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Role of MAP kinase pathways in mediating IL-6 production in human primary mesangial and proximal tubular cells.
    Leonard M; Ryan MP; Watson AJ; Schramek H; Healy E
    Kidney Int; 1999 Oct; 56(4):1366-77. PubMed ID: 10504489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways.
    Bancroft CC; Chen Z; Dong G; Sunwoo JB; Yeh N; Park C; Van Waes C
    Clin Cancer Res; 2001 Feb; 7(2):435-42. PubMed ID: 11234901
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MEK1 and Erk1/2 kinases as targets for the modulation of radiation responses.
    Belka C; Knippers P; Rudner J; Faltin H; Bamberg M; Budach W
    Anticancer Res; 2000; 20(5A):3243-9. PubMed ID: 11062749
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Activation of Erk1/2 and Akt in astrocytes under ischemia.
    Jiang Z; Zhang Y; Chen X; Lam PY; Yang H; Xu Q; Yu AC
    Biochem Biophys Res Commun; 2002 Jun; 294(3):726-33. PubMed ID: 12056831
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacologic inhibitors of MKK1 and MKK2.
    Ahn NG; Nahreini TS; Tolwinski NS; Resing KA
    Methods Enzymol; 2001; 332():417-31. PubMed ID: 11305115
    [No Abstract]   [Full Text] [Related]  

  • 50. Prohibitin is required for Ras-induced Raf-MEK-ERK activation and epithelial cell migration.
    Rajalingam K; Wunder C; Brinkmann V; Churin Y; Hekman M; Sievers C; Rapp UR; Rudel T
    Nat Cell Biol; 2005 Aug; 7(8):837-43. PubMed ID: 16041367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extracellular signal-regulated kinase 1/2-mediated phosphorylation of cytosolic phospholipase A2 is essential for human eosinophil adhesion to fibronectin.
    Sano H; Zhu X; Sano A; Boetticher EE; Shioya T; Jacobs B; Munoz NM; Leff AR
    J Immunol; 2001 Mar; 166(5):3515-21. PubMed ID: 11207311
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fibroblast growth factor-2 and -4 promote the proliferation of bone marrow mesenchymal stem cells by the activation of the PI3K-Akt and ERK1/2 signaling pathways.
    Choi SC; Kim SJ; Choi JH; Park CY; Shim WJ; Lim DS
    Stem Cells Dev; 2008 Aug; 17(4):725-36. PubMed ID: 18788932
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PAK1 phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation.
    Slack-Davis JK; Eblen ST; Zecevic M; Boerner SA; Tarcsafalvi A; Diaz HB; Marshall MS; Weber MJ; Parsons JT; Catling AD
    J Cell Biol; 2003 Jul; 162(2):281-91. PubMed ID: 12876277
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prosurvival and proapoptotic functions of ERK1/2 activation in murine thymocytes in vitro.
    Smirnova IS; Chang S; Forsthuber TG
    Cell Immunol; 2010; 261(1):29-36. PubMed ID: 19914607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of novel MAP kinase pathway signaling targets by functional proteomics and mass spectrometry.
    Lewis TS; Hunt JB; Aveline LD; Jonscher KR; Louie DF; Yeh JM; Nahreini TS; Resing KA; Ahn NG
    Mol Cell; 2000 Dec; 6(6):1343-54. PubMed ID: 11163208
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells.
    Tseng CP; Huang CL; Huang CH; Cheng JC; Stern A; Tseng CH; Chiu DT
    FEBS Lett; 2003 Apr; 541(1-3):21-7. PubMed ID: 12706813
    [TBL] [Abstract][Full Text] [Related]  

  • 57. ERK2-Pyruvate Kinase Axis Permits Phorbol 12-Myristate 13-Acetate-induced Megakaryocyte Differentiation in K562 Cells.
    Chaman N; Iqbal MA; Siddiqui FA; Gopinath P; Bamezai RN
    J Biol Chem; 2015 Sep; 290(39):23803-15. PubMed ID: 26269597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Phorbol ester-induced migration of HepG2 cells is accompanied by intensive stress fibre formation, enhanced integrin expression and transient down-regulation of p21-activated kinase 1.
    Gujdár A; Sipeki S; Bander E; Buday L; Faragó A
    Cell Signal; 2003 Mar; 15(3):307-18. PubMed ID: 12531429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the potassium current IK(SO), in cerebellar granule cells, by the inhibitors of MEK1 activation, PD 98059 and U 0126.
    Boyd DF; Mathie A
    Neuropharmacology; 2002 Feb; 42(2):221-8. PubMed ID: 11804618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Targeting the ERK-1/2 signalling pathway results in alloantigen-specific anergy in human T cells.
    Krieger PM; Säemann MD; Böhmig GA; Mühlbacher F; Zlabinger GJ
    Transplant Proc; 2002 Aug; 34(5):1403-4. PubMed ID: 12176416
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.